Tenaya Therapeutics, Inc. (TNYA) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$68.26M | +24.6% |
| 2024 | -$90.50M | +11.3% |
| 2023 | -$102.07M | +2.3% |
| 2022 | -$104.42M | -71.7% |
| 2021 | -$60.81M | -71.6% |
| 2020 | -$35.45M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$68.26M | +24.6% |
| 2024 | -$90.50M | +11.3% |
| 2023 | -$102.07M | +2.3% |
| 2022 | -$104.42M | -71.7% |
| 2021 | -$60.81M | -71.6% |
| 2020 | -$35.45M | — |